From the Journals
FDA & Government News
FDA Clears Rayner's Sophi Phaco System
The company said that surgeons and clinical teams can benefit from faster setup, quicker patient turnover, and greater mobility.
Rayner has received FDA 510(k) clearance for Sophi, a new phacoemulsification system designed to enhance efficiency in ambulatory surgical centers (ASCs), office-based surgery, and hospitals. The system features innovative triple pump fluidics, an intuitive user interface, and a wireless power concept that enables faster setup and patient turnover without compromising safety. CEO Tim Clover emphasizes the need for alternative phaco technology and highlights Sophi's potential to reduce surgical waste and carbon footprint significantly.
